Status:
UNKNOWN
Renal Protocol Protection in CKD Patients
Lead Sponsor:
Seoul National University Hospital
Conditions:
HCC
CKD
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study aims to investigate whether acceptable image quality is achievable using low contrast media dose and low keV imaging in chronic kidney disease.
Eligibility Criteria
Inclusion
- High risk group for developing HCC
- Scheduled contrast-enhanced CT for HCC diagnosis or surveillance
- chronic kidney disease (Estimated GFR \< 60mL/min/1.73m2)
Exclusion
- not a high risk group for developing HCC
- congestive hepatopathy
- on dialysis
- no venous access on forearm
- anticipated beam hardening artifact due to prosthesis
- relative/absolute contra-indication of contrast-enhanced CT except CKD (Estimated GFR \< 60mL/min/1.73m2)
Key Trial Info
Start Date :
December 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04024514
Start Date
December 24 2019
End Date
September 30 2023
Last Update
March 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea